Veracode Reveals Automation and Training Are Key Drivers of Software Security for Financial Services
72% of Financial Services Applications Contain Security Flaws; API-launched Scanning and Interactive Security Training Drop Probability of Flaw Introduction to 22%... Read more.
United Bankshares, Inc. Announces Earnings for the Third Quarter and First Nine Months of 2023
WASHINGTON & CHARLESTON, W.Va.–(BUSINESS WIRE)–United Bankshares, Inc. (NASDAQ: UBSI) (“United”), today reported earnings for the third quarter... Read more.
LongWater Opportunities Launches Private Credit and Capital Solutions Strategy
Strategy to Be Led by Highly Successful Eight-Person Team With Expertise in Private Credit, and Equity Co-Investment and Primary LP Equity Commitments to GPs Significantly... Read more.
Global Respiratory Care Medical Devices Market Set to Reach US$24.08 Billion by 2023, Fueled by Rising Incidence of Respiratory Disorders and Technological Advancements – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Care Medical Devices Market (by Disorder, Product Type, End User, & Region): Insights and Forecast... Read more.
Lazard Declares Quarterly Dividend of $0.50 Per Share
NEW YORK–(BUSINESS WIRE)–Lazard Ltd (NYSE: LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share... Read more.
Hummingbird Diagnostics GmbH to Unveil Pioneering Alzheimer’s Disease Biomarker Research at CTAD Conference
HEIDELBERG, Germany–(BUSINESS WIRE)–Hummingbird Diagnostics GmbH, a leader in blood-based small RNA detection and characterization, today announced the... Read more.
Giving Agents Financial Freedom Takes Center Stage at the Real RISE 2023 Conference
Real empowers agent success with revenue-sharing post-retirement; unveils wealth-building tools and longer term vision of the “Real Wallet” that provides rewards... Read more.
Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program
– New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis – –... Read more.
Hess Reports Estimated Results for the Third Quarter of 2023
Key Development: On October 23rd the Corporation entered into an agreement to merge with Chevron. The transaction is expected to close in the first half of 2024... Read more.
Monro, Inc. Announces Second Quarter Fiscal 2024 Financial Results
Second Quarter Sales Decreased to $322.1 Million Second Quarter Comparable Store Sales Decreased 2.3% Second Quarter Diluted EPS of $.40; Adjusted Diluted EPS1 of... Read more.